The largest database of trusted experimental protocols

Anti lat1

Manufactured by Cell Signaling Technology
Sourced in United States

Anti-LAT1 is a primary antibody that targets the LAT1 protein. LAT1 is a neutral amino acid transporter that facilitates the uptake of essential amino acids into cells. This antibody can be used to detect and analyze the expression of the LAT1 protein.

Automatically generated - may contain errors

4 protocols using anti lat1

1

Western Blot Antibody Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-S6K (#9202), anti-phospho S6K Thr389 (#9234), anti-AKT (#9272), anti-phospho AKT Ser473 (#9271), anti-LAT1 (#5347), anti-mTOR (#2983), anti-Raptor (#2280), anti-Flag (#14793), and anti-Rictor (#2140) were purchased from Cell Signaling Technology. Anti-tubulin (05-829) was purchased from Millipore. Anti-β-actin (A700-057) and anti-Flag M2 (F1804) were purchased from Sigma. HA-horseradish peroxidase (HRP) (11-814-150-001) was purchased from Roche. Anti-HA (sc-7392) was purchased from Santa Cruz Biotechnology. Anti-LAMP2 (ab25631) and anti-sodium potassium ATPase (ab76020) were purchased from Abcam.
+ Open protocol
+ Expand
2

Antibody Validation for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-LAT1 (#5347), anti-4F2hc (#47213), anti-xCT/SLC7A11 (#12691) and anti-HA (#3724) were purchased from Cell Signaling. Anti-SCRIB (C-20), anti-SCRIB (C-2), anti-LLGL2 antibody (A-4), anti-CD98 (4F2), anti-CD98 (E-5), anti-Erk2 (C-14), and anti-cyclin D1 (H-295) were purchased from Santa Cruz. Anti-HA, anti-CD98hc (BMP090), anti-SLC7A5 (BMP011), and anti-DDDDK-tag (M185) antibodies were purchased from MBL. Anti-SLC7A5 (HPA052673) and anti-SCRIB (HPA023557) antibodies were purchased from ATLAS ANTIBODIES. Anti-Flag antibody (M2) was purchased from Sigma.
+ Open protocol
+ Expand
3

Profiling Luminal ER-positive Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luminal estrogen-receptor (ER)-positive breast cancer (BC) cell lines (MCF7, T47D, ZR-75-1) were acquired from the American Type Culture Collection (Manassas, VA, USA) and cultured at 37 °C with 5% CO2. MCF7 was cultured in DMEM/F12 with 10% fetal bovine serum (FBS) and Penicillin-Streptomycin (P/S). T47D and ZR-75-1 were cultured in RPMI-1640 with 10% FBS and P/S. Media, P/S and FBS were purchased from Thermo Fisher Scientific (Waltham, MA, USA). 2-Amino-2-norbornanecarboxylic acid (BCH), JPH203 (KYT-0353) and Dimethyl sulfoxide (DMSO) were acquired from Sigma-Aldrich (St. Louis, MO, USA). Stock BCH (100 mM) was prepared in media. Stock JPH-203 (1 mg/mL; 2.1 mM) was prepared in DMSO. Antibodies were acquired from Cell Signaling Technology (Danvers, MA, USA): anti-LAT1 (rabbit), anti-CD98 (rabbit), anti-S6 Ribosomal Protein (rabbit), β-Actin (rabbit), anti-Phospho-S6 Ribosomal Protein (Ser235/236).
+ Open protocol
+ Expand
4

Analyzing MET and Akt Phosphorylation Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were subjected to starvation treatment (cultured in RPMI 1640 medium without addition of FBS) for 24 h, and then phosphorylation stimulation was performed. Hepatocyte growth factor (HGF) was purchased from PeproTech (Shanghai, China) as a stimulus for MET phosphorylation. Phosphorylation stimulation with HGF was performed at 40 ng/mL for 10 min. For Akt phosphorylation, cells were plated in medium supplemented with 10% FBS for 10 min. Antibodies anti-Akt (pan, rabbit IgG, cat no. #4691), phospho-Akt (rabbit IgG, Ser 473, #4060), anti-MET (rabbit IgG, #8198), phospho-MET (rabbit IgG, Tyr 1234/1235, #3077), anti-SLC1A5 (#4692), and anti-LAT1 (#5347) were purchased from Cell Signaling Technology (Danvers, MA, USA), and GAPDH (sc-32233) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!